je.st
news
Merck in talks to acquire Cubist Pharmaceuticals for more than $7 billion - NYT
2014-12-06 06:44:09| Biotech - Topix.net
Merck & Co Inc is in talks to acquire Cubist Pharmaceuticals Inc for more than $7 billion in a deal that could be announced as early as next week, the New York Times reported on Friday, citing people briefed on the matter. Merck will likely pay roughly $100 a share for Cubist, valuing the company that makes drugs to fight superbugs, in the range of $7.5 billion, the people said.
Tags: than
billion
talks
acquire
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||